Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
3D-BONE: Ein 3D Model des Immun-Knochenmilieus zur Metastasenforschung
Vallet, S. (PI)
01.03.2025 → 28.02.2027
Project: Forschungsimpulse › Seed Funding
-
Fight Cancer: Unraveling the pathogenesis to improve treatment of cancer metastasis
Vallet, S. (PI)
01.03.2024 → 28.02.2027
Project: Forschungsimpulse › Research Time Out (RTO)
-
Breast Cancer: Uncovering new checkpoints in natural killer cells to prevent breast cancer metastasis
Witalisz-Siepracka, A. (PI), Vallet, S. (CoPI) & Gotthardt, D. (CoPI)
Gesellschaft für Forschungsförderung NÖ (GFF)
01.12.2022 → 30.11.2026
Project: Funded Research
-
Untersuchung der Effekte von Immun-Checkpoint Inhibitoren auf den Knochenumbau.
Vallet, S. (PI)
01.11.2021 → 30.11.2023
Project: Forschungsimpulse › Seed Funding
-
BONE: Biomarker- based therapeutic prevention of bone metastases in breast cancer: Defining the pathophysiologic impact of the endosteal niche
Vallet, S. (PI)
01.08.2020 → 31.12.2023
Project: Forschungsimpulse › Research Time Out (RTO)
Research output
-
PYCR1 inhibition in bone marrow stromal cells enhances bortezomib sensitivity in multiple myeloma cells by altering their metabolism
Oudaert, I., van den Broecke, L., Aksoy, O., Lind, J., Vallet, S., Van der Vreken, A., Ates, G., Massie, A., Maes, K., De Veirman, K., De Bruyne, E., Vanderkerken, K., Podar, K. & Menu, E., Feb 2026, In: Molecular Oncology. 20, 2, p. 447-463 17 p.Research output: Journal article (peer-reviewed) › Journal article
Open Access -
Can we develop effective direct or indirect inhibitors of transcription factors? On the clinical evolution of protein degraders for multiple myeloma therapy
Meli, R., Aksoy, O., Vallet, S., Slade, D. & Podar, K., 2025, In: Expert Opinion on Therapeutic Targets. 29, 3, p. 101-115 15 p.Research output: Journal article (peer-reviewed) › Journal article
1 Link opens in a new tab Citation (Scopus) -
DDX3X facilitates adaption to proteotoxic stress by regulating the translation of MAPKAPK2 and the stability of TMCO1 via stress granules in multiple myeloma
Fan, F., Jiang, S., Ni, E., Wang, Z., Wang, Y., Zuo, L., Ma, C., Vallet, S., Xu, A., Xu, J., Podar, K., Sun, C. & Hu, Y., 03 Nov 2025, In: Blood. 146, Supplement 1, p. 3944-3944Research output: Journal article (peer-reviewed) › Conference contribution to journal
-
Effectiveness, toxicity and treatment adjustments of lenvatinib plus pembrolizumab in advanced renal cell carcinoma: a multicenter real-world analysis
Stelmach, R., Erdmann, S., Schlack, K., Muehle, C., Darr, C., Neuberger, S., Reichert, M., Flegar, L., Egenolf, T., Rehlinghaus, M., Zengerling, F., Casuscelli, J., Cox, A., Vallet, S., Nestler, T., Brehmer, B., Ivanyi, P., Paffenholz, P., Neuberger, M. & Jäger, D. & 2 others, , Jun 2025, In: ESMO real world data and digital oncology. 8, p. 100142Research output: Journal article (peer-reviewed) › Journal article
Open Access -
Enfortumab vedotin plus pembrolizumab in treatment-naïve metastatic urothelial carcinoma patients: An Austrian real-world analysis
Niedersuess-Beke, D., Mayrhofer, K., Krauter, J., Franke, J., Vais, D., Pallauf, M., Kiesl, D., Luger, F., Pfuner, J., Terbuch, A., Bauernhofer, T., Spielgelberg, J., Banner, A., Aufderklamm, S., Wiesinger, C., Schnabel, S., Gampenrieder, S. P., Mühlmann, J., Vallet, S. & Weibrecht, S. & 11 others, , 15 Mar 2026, In: International Journal of Cancer. 158, 6, p. 1654-1665 12 p.Research output: Journal article (peer-reviewed) › Journal article
Open Access
Prizes
-
Wissenschaftspreis des Landes Niederösterreich 2022
Vallet, S. (Recipient), 2022
Prize: Honorary award
-
Lower Austrian Conference on Cancer Research (LACCR)
Podar, K. (Organiser) & Vallet, S. (Co-Organiser)
13 Nov 2025Activity: Participating in/organising an event › Organising an event (Science to science)
-
Österreichische Gesellschaft für Hämatologie & Medizinische Onkologie (OeGHO) (External organisation)
Vallet, S. (Member)
2022Activity: Membership
-
European Society for Medical Oncology (External organisation)
Vallet, S. (Member)
2022 → …Activity: Membership
-